Trial Profile
Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2022
Price :
$35
*
At a glance
- Drugs Lofexidine (Primary) ; Naltrexone (Primary)
- Indications Opioid-related disorders
- Focus Pharmacokinetics
- Sponsors US WorldMeds
- 29 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 May 2015 New trial record